396 related articles for article (PubMed ID: 36411859)
1. Remimazolam: An Updated Review of a New Sedative and Anaesthetic.
Hu Q; Liu X; Wen C; Li D; Lei X
Drug Des Devel Ther; 2022; 16():3957-3974. PubMed ID: 36411859
[TBL] [Abstract][Full Text] [Related]
2. Remimazolam: A Review in Procedural Sedation.
Lee A; Shirley M
Drugs; 2021 Jul; 81(10):1193-1201. PubMed ID: 34196946
[TBL] [Abstract][Full Text] [Related]
3. Remimazolam - current knowledge on a new intravenous benzodiazepine anesthetic agent.
Kim SH; Fechner J
Korean J Anesthesiol; 2022 Aug; 75(4):307-315. PubMed ID: 35585830
[TBL] [Abstract][Full Text] [Related]
4. Remimazolam versus traditional sedatives for procedural sedation: a systematic review and meta-analysis of efficacy and safety outcomes.
Tang Y; Yang X; Yu Y; Shu H; Xu J; Li R; Zou X; Yuan S; Shang Y
Minerva Anestesiol; 2022 Nov; 88(11):939-949. PubMed ID: 35785930
[TBL] [Abstract][Full Text] [Related]
5. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.
Antonik LJ; Goldwater DR; Kilpatrick GJ; Tilbrook GS; Borkett KM
Anesth Analg; 2012 Aug; 115(2):274-83. PubMed ID: 22190555
[TBL] [Abstract][Full Text] [Related]
6. A Phase IIa, randomized, double-blind study of remimazolam (CNS 7056) versus midazolam for sedation in upper gastrointestinal endoscopy.
Borkett KM; Riff DS; Schwartz HI; Winkle PJ; Pambianco DJ; Lees JP; Wilhelm-Ogunbiyi K
Anesth Analg; 2015 Apr; 120(4):771-80. PubMed ID: 25502841
[TBL] [Abstract][Full Text] [Related]
7. Remimazolam: its clinical pharmacology and evolving role in anesthesia and sedation practice.
Masui K
Curr Opin Anaesthesiol; 2024 Aug; 37(4):344-351. PubMed ID: 38841907
[TBL] [Abstract][Full Text] [Related]
8. Remimazolam for anaesthesia or sedation.
Sneyd JR; Rigby-Jones AE
Curr Opin Anaesthesiol; 2020 Aug; 33(4):506-511. PubMed ID: 32530890
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of remimazolam tosylate for sedation during upper gastrointestinal endoscopy: study protocol for a multicenter randomized controlled trial.
Zhu H; Su Z; Huai X; Chen C; Zhang X; Zhou J; Su D
Trials; 2022 Dec; 23(1):995. PubMed ID: 36510290
[TBL] [Abstract][Full Text] [Related]
10. Psychomotor Recovery Following Remimazolam-induced Sedation and the Effectiveness of Flumazenil as an Antidote.
Chen X; Sang N; Song K; Zhong W; Wang H; Jiang J; Huang Y; Hu P
Clin Ther; 2020 Apr; 42(4):614-624. PubMed ID: 32178858
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamic analysis of intravenous bolus remimazolam for loss of consciousness in patients undergoing general anaesthesia: a randomised, prospective, double-blind study.
Chae D; Kim HC; Song Y; Choi YS; Han DW
Br J Anaesth; 2022 Jul; 129(1):49-57. PubMed ID: 35562226
[TBL] [Abstract][Full Text] [Related]
12. Clinical Application and Research Progress of Remimazolam for Pediatric Patients.
Bai C; Xu M; Guo Y; Jin Y; Zhao X
Drug Des Devel Ther; 2024; 18():1221-1229. PubMed ID: 38645987
[TBL] [Abstract][Full Text] [Related]
13. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
[TBL] [Abstract][Full Text] [Related]
14. A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy.
Pambianco DJ; Borkett KM; Riff DS; Winkle PJ; Schwartz HI; Melson TI; Wilhelm-Ogunbiyi K
Gastrointest Endosc; 2016 May; 83(5):984-92. PubMed ID: 26363333
[TBL] [Abstract][Full Text] [Related]
15. Remimazolam: First Approval.
Keam SJ
Drugs; 2020 Apr; 80(6):625-633. PubMed ID: 32274703
[TBL] [Abstract][Full Text] [Related]
16. Sedation outcomes for remimazolam, a new benzodiazepine.
Oka S; Satomi H; Sekino R; Taguchi K; Kajiwara M; Oi Y; Kobayashi R
J Oral Sci; 2021 Jun; 63(3):209-211. PubMed ID: 34092775
[TBL] [Abstract][Full Text] [Related]
17. Remimazolam, a short-acting GABA(A) receptor agonist for intravenous sedation and/or anesthesia in day-case surgical and non-surgical procedures.
Rogers WK; McDowell TS
IDrugs; 2010 Dec; 13(12):929-37. PubMed ID: 21154153
[TBL] [Abstract][Full Text] [Related]
18. Economic benefits of remimazolam compared to midazolam and propofol for procedural sedation in colonoscopies and bronchoscopies.
Pedersen MH; Danø A; Englev E; Kattenhøj L; Munk E
Curr Med Res Opin; 2023 May; 39(5):691-699. PubMed ID: 36999319
[TBL] [Abstract][Full Text] [Related]
19. Remimazolam: Non-Clinical and Clinical Profile of a New Sedative/Anesthetic Agent.
Kilpatrick GJ
Front Pharmacol; 2021; 12():690875. PubMed ID: 34354587
[TBL] [Abstract][Full Text] [Related]
20. Remimazolam: A Novel Option for Procedural Sedation in High Risk Patients.
Pantos MM; Kennedy DR; Nemec EC
J Pharm Pract; 2023 Feb; 36(1):149-154. PubMed ID: 34155946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
